Community-Acquired Pneumonia

General
Facts and Figures
Classification

Presentation
History
Physical Exam
Labs
Radiology

Diagnosis
Criteria for diagnosis
Differential

Microbiology
General
Specific organisms

Pharmacology
Drug Classes
Mechanism of action
Resistance

Treatment
General
Site of care
Medication
Duration
Assessment of response
Prevention

References
Literature cited
Complete bibliography

Links
More...






Pharmacology

Mechanism of Action

  • cell wall synthesis inhibitors
    • beta-lactams - 4-membered beta-lactam ring interacts with bacterial enzymes (penicillin-binding proteins - PBPs) to prevent cross-linking of peptidogylcan
    • vancomycin - inhibits peptidoglycan synthesis; large molecule - does not penetrate outer membrane of gram-negatives
    • cycloserine - inhibits enzymes involved in peptidogycan synthesis

  • DNA synthesis inhibitors
    • trimethoprim/sulfonamides - inhibit folic acid metabolism by competitively blocking biosynthesis of tetrahydrofolate (drugs act at different steps in the pathway)
    • metronidazole - drug is reduced in bacteria and causes breaks in DNA
    • quinolones - bind to DNA gyrase and inhibit replication

  • Inhibitors of translation and transcription
    • aminoglycosides - bind to 30S ribosomal subunit and inhibit protein synthesis
    • tetracyclines - bind to 30S ribosomal subunit, prevent binding of tRNA and inhibit protein synthesis
    • macrolides - bind to 50S ribosomal subunit and inhibit protein synthesis
    • clindamycin - bind to 50S ribosomal subunit and inhibit protein synthesis
    • chloramphenicol - bind to 50S ribosomal subunit and inhibit protein synthesis
    • rifampin - binds to RNA polymerase and prevents initiation

There's no place like home... Top of page
© Copyright 1999, All rights reserved. L. España. Rev. 3/99
medschool.ucsd.edu/curricular_resources/MED/CAP/index.html   3/30/99